Related Experiment Video
Updated: Jul 18, 2026

Determination of Total Lipid and Lipid Classes in Marine Samples
Published on: December 11, 2021
Analysis of veterinary drug residues in fish and shrimp composites collected during the Canadian Total Diet Study,
S A Tittlemier1, J Van de Riet, G Burns
1Food Research Division, Health Canada, Ottawa, ON, Canada K1A 0L2. Sheryl_Tittlemier@hc-sc.gc.ca
Abstract:
Thirty shrimp, marine fish, freshwater fish, and canned fish composite samples collected and prepared as part of the Canadian Total Diet Study were analysed for 39 different veterinary drug residues. The analyses were undertaken to obtain baseline data that could be used to estimate the dietary exposure of Canadians to these residues. The most frequently observed residue was AOZ (four out of 30 samples), the metabolite of furazolidone, at a range of 0.50 to 2.0 ng g(-1) wet weight. Other residues detected included enrofloxacin (three samples; 0.3-0.73 ng g(-1)), leucomalachite green (three samples; 0.73-1.2 ng g(-1)), oxolinic acid (two samples; 0.3-4.3 ng g(-1)), AMOZ (the metabolite of furaltadone; one sample; 0.40 ng g(-1)), chloramphenicol (one sample; 0.40 ng g(-1)), and SEM (the metabolite of nitrofurazone; one sample; 0.8 ng g(-1)). The results of this survey indicate that Canadians are exposed to low ng g-1 concentrations of some banned and unapproved veterinary drug residues via the consumption of certain fish and shrimp.
More Related Videos
12:02Using Tg(Vtg1:mcherry) Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds
Published on: August 8, 2020
16:03A Fish-feeding Laboratory Bioassay to Assess the Antipredatory Activity of Secondary Metabolites from the Tissues of Marine Organisms
Published on: January 11, 2015
Related Concept Videos
Toxicity Testing in Animals
Therapeutic Drug Monitoring: Drug Analysis Methods